Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis

Evaluating Outcomes Associated with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Qualitative Systematic Review

(2012) G. T. Mah et al.   ANNALS OF PHARMACOTHERAPY

Optimal Meropenem Concentrations To Treat Multidrug-Resistant Pseudomonas aeruginosa Septic Shock

(2012) Fabio Silvio Taccone et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design

(2012) Konstantinos Z. Vardakas et al.   MAYO CLINIC PROCEEDINGS

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials

(2011) Pranita D Tamma et al.   BMC INFECTIOUS DISEASES

Elderly Patients with Community-Acquired Pneumonia

(2011) Ulrich Thiem et al.   DRUGS & AGING

Monotherapy or Combination Therapy? ThePseudomonas aeruginosaConundrum

(2011) Kristi A Traugott et al.   PHARMACOTHERAPY

The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) Study: A Multicenter Study

(2011) Raymond J Yost et al.   PHARMACOTHERAPY

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia

(2011) Ioannis A. Bliziotis et al.   PLoS One

Comparing Outcomes of Meropenem Administration Strategies Based on Pharmacokinetic and Pharmacodynamic Principles: A Qualitative Systematic Review

(2010) Jerrold Perrott et al.   ANNALS OF PHARMACOTHERAPY

Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia

(2010) Aryun Kim et al.   CLINICAL THERAPEUTICS

Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation

(2010) Lois S. Lee et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Treatment ofAcinetobacterinfections

(2010) Argyris Michalopoulos et al.   EXPERT OPINION ON PHARMACOTHERAPY

Comparison of the Pharmacodynamics of Biapenem in Bronchial Epithelial Lining Fluid in Healthy Volunteers Given Half-Hour and Three-Hour Intravenous Infusions

(2009) E. Kikuchi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections

(2009) Gita Wasan Patel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion

(2009) Leonardo Lorente et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

(2009) Jason A. Roberts et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Use of Carbapenems in the Treatment of Serious Infections

(2009) Robert P. Baughman   JOURNAL OF INTENSIVE CARE MEDICINE

Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii

(2008) Donghao Wang   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS